A GGT‐Activatable Chiral Gadolinium Polymer Probe for Dual‐Modal MR/NIRF Imaging of Glioma
Advanced Healthcare Materials · 2026
DOI: 10.1002/adhm.71719 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2026. Verfasst von Xinlan Zhou und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China. Hauptthemen laut MEDLINE: Glioma, Magnetic Resonance Imaging, Gadolinium, gamma-Glutamyltransferase. Die Arbeit nennt 39 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Zhejiang Provincial Natural Science of Foundation of China, Natural Science Foundation of Hunan Province.
Abstract (Originalsprache)
Magnetic resonance imaging (MRI) offers noninvasive, radiation‐free anatomical imaging but is inherently constrained by poor sensitivity for molecular event detection. To address this, we present PAA‐Gd‐ γ ‐GT , an enzyme‐activatable dual‐modal probe that synergizes MRI's anatomical precision with the exceptional sensitivity of near‐infrared fluorescence (NIRF). The probe integrates a chiral Gd‐DOTA complex featuring optimized water‐exchange kinetics, a poly(acrylic acid) (PAA) scaffold for relaxivity enhancement, and a γ ‐glutamyl‐caged NIRF fluorophore for tumor‐selective activation. The probe exhibits a remarkable baseline relaxivity ( r 1 ) of 16.1 mM −1 s −1 , which further increases to 21.3 mM −1 s −1 upon GGT‐mediated cleavage and subsequent albumin binding, a nearly sevenfold enhancement over clinically used Gd‐DOTA (3.0 mM −1 s −1 ). Notably, postactivation intermediates enable prolonged retention within orthotopic gliomas via interaction with local biomolecules, ensuring sustained contrast without compromising biocompatibility. This design affords concurrent tumor delineation via T 1 ‐weighted MRI and molecular validation via NIRF, establishing a robust, enzyme‐responsive multimodal platform with translational potential for glioma margin identification and image‐guided surgery.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiology, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
- MOE Key Laboratory of Theoretical Organic Chemistry and Function Molecule, School of Chemistry and Chemical Engineering, Hunan University of Science and Technology, Xiangtan, Hunan, China.
- Wenzhou Key Laboratory of Biophysics, Wenzhou Institute, University of Chinese Academy of Sciences, Wenzhou, Zhejiang, China.
- Department of Cell Biology & Medical Genetics, School of Basic Medical Sciences, Shenzhen University School of Medicine, Shenzhen, Guangdong, China.
ORCID-Profile: Xinlan Zhou, Xinjian Ye, Yong Jian, Fangfu Ye, Rongfeng Lan, Yi Li, Lixiong Dai
Förderung
- National Natural Science Foundation of China
- Zhejiang Provincial Natural Science of Foundation of China
- Natural Science Foundation of Hunan Province
Zitieren
APA
Zhou, X., Mo, G., Ye, X., Ding, Y., Xiao, X., Xu, W., Chen, A., Zhang, J., Jian, Y., Ye, F., Lan, R., Li, Y., & Dai, L. (2026). A GGT‐Activatable Chiral Gadolinium Polymer Probe for Dual‐Modal MR/NIRF Imaging of Glioma. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.71719
Vancouver
Zhou X, Mo G, Ye X, Ding Y, Xiao X, Xu W, et al. A GGT‐Activatable Chiral Gadolinium Polymer Probe for Dual‐Modal MR/NIRF Imaging of Glioma. Advanced Healthcare Materials. 2026. doi:10.1002/adhm.71719
BibTeX
@article{Zhou2026,
author = {Zhou, Xinlan and Mo, Gengshen and Ye, Xinjian and Ding, Yinghui and Xiao, Xinhui and Xu, Weiyuan and Chen, Aiyi and Zhang, Jilai and Jian, Yong and Ye, Fangfu and Lan, Rongfeng and Li, Yi and Dai, Lixiong},
title = {A GGT‐Activatable Chiral Gadolinium Polymer Probe for Dual‐Modal MR/NIRF Imaging of Glioma},
journal = {Advanced Healthcare Materials},
year = {2026},
doi = {10.1002/adhm.71719}
}
EUVIMED